SCHEMBL4350819

SCHEMBL4350819

COc1c(Cl)cncc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
PDE4D Q08499 10/20 0.47
TPMT P51580 1/20 0.43
MAPT P10636 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
NOTUM Q6P988 1/20 0.39
PDE4B Q07343 1/20 0.39
LIPE Q05469 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15775500 0.79 HSD17B10 (0.56) HSD17B10ALDH1A1KDM4ETPMTMAPT
SCHEMBL3558535 0.79 KDM4E (0.42) HSD17B10ALDH1A1KDM4EPDE4DMAPT
SCHEMBL19063459 0.76 PDE4D (0.42) HSD17B10ALDH1A1KDM4EPDE4DTPMT
SCHEMBL28440693 0.75 AKR1C2 (0.52) HSD17B10ALDH1A1KDM4EMAPTTDP1
SCHEMBL392397 0.75 TSHR (0.48) ALDH1A1KDM4EMAPTTDP1MEN1
SCHEMBL5765625 0.75 PPARG (0.45)
SCHEMBL30084374 0.73 ACLY (0.56) HSD17B10ALDH1A1KDM4ETPMTMAPT
SCHEMBL423692 0.73 ACLY (0.56) HSD17B10ALDH1A1KDM4ETPMTMAPT
SCHEMBL477714 0.73 TSHR (0.57) HSD17B10ALDH1A1KDM4EMAPTTDP1
SCHEMBL29157397 0.72 HCAR2 (0.39) ALDH1A1KDM4EMAPTTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069305-A2 NICOTINIC ACID DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Novartis AG (CH) 2009-06-17 EP disclosed
WO-2008031550-A2 NICOTINIC ACID DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTANATE RECEPTORS NOVARTIS AG (CH) 2008-03-20 WO disclosed